235 related articles for article (PubMed ID: 18161478)
1. Relaxin, the relaxin-like factor and their receptors.
Schwabe C; Büllesbach EE
Adv Exp Med Biol; 2007; 612():14-25. PubMed ID: 18161478
[TBL] [Abstract][Full Text] [Related]
2. Genetic targeting of relaxin and insl3 signaling in mice.
Feng S; Bogatcheva NV; Kamat AA; Agoulnik AI
Ann N Y Acad Sci; 2005 May; 1041():82-90. PubMed ID: 15956690
[TBL] [Abstract][Full Text] [Related]
3. Partial cDNA sequence of a relaxin-like factor (RLF) receptor, LGR8 and possible existence of the RLF ligand-receptor system in goat testes.
Siqin ; Nakai M; Hagi T; Kato S; Pitia AM; Kotani M; Odanaka Y; Sugawara Y; Hamano K; Yogo K; Nagura Y; Fujita M; Sasada H; Sato E; Kohsaka T
Anim Sci J; 2010 Dec; 81(6):681-6. PubMed ID: 21108688
[TBL] [Abstract][Full Text] [Related]
4. Coevolution of the relaxin-like peptides and their receptors.
Wilkinson TN; Speed TP; Tregear GW; Bathgate RA
Ann N Y Acad Sci; 2005 May; 1041():534-9. PubMed ID: 15956757
[TBL] [Abstract][Full Text] [Related]
5. Relaxin-family peptide and receptor systems in brain: insights from recent anatomical and functional studies.
Ma S; Gundlach AL
Adv Exp Med Biol; 2007; 612():119-37. PubMed ID: 18161485
[TBL] [Abstract][Full Text] [Related]
6. LGR7-truncate is a splice variant of the relaxin receptor LGR7 and is a relaxin antagonist in vitro.
Scott DJ; Tregear GW; Bathgate RA
Ann N Y Acad Sci; 2005 May; 1041():22-6. PubMed ID: 15956683
[TBL] [Abstract][Full Text] [Related]
7. Relaxin research in the postgenomic era.
Kawamura K; Sudo S; Kumagai J; Pisarska M; Hsu SY; Bathgate R; Wade J; Hsueh AJ
Ann N Y Acad Sci; 2005 May; 1041():1-7. PubMed ID: 15956679
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the mouse and rat relaxin receptors.
Scott DJ; Layfield S; Riesewijk A; Morita H; Tregear GW; Bathgate RA
Ann N Y Acad Sci; 2005 May; 1041():8-12. PubMed ID: 15956680
[TBL] [Abstract][Full Text] [Related]
9. Relaxin signaling in reproductive tissues.
Hsu SY; Nakabayashi K; Nishi S; Kumagai J; Kudo M; Bathgate RA; Sherwood OD; Hsueh AJ
Mol Cell Endocrinol; 2003 Apr; 202(1-2):165-70. PubMed ID: 12770746
[TBL] [Abstract][Full Text] [Related]
10. Identification of binding sites with differing affinity and potency for relaxin analogues on LGR7 and LGR8 receptors.
Halls ML; Bathgate RA; Sudo S; Kumagai J; Bond CP; Summers RJ
Ann N Y Acad Sci; 2005 May; 1041():17-21. PubMed ID: 15956682
[TBL] [Abstract][Full Text] [Related]
11. Multiple binding sites revealed by interaction of relaxin family peptides with native and chimeric relaxin family peptide receptors 1 and 2 (LGR7 and LGR8).
Halls ML; Bond CP; Sudo S; Kumagai J; Ferraro T; Layfield S; Bathgate RA; Summers RJ
J Pharmacol Exp Ther; 2005 May; 313(2):677-87. PubMed ID: 15649866
[TBL] [Abstract][Full Text] [Related]
12. Defining the LGR8 residues involved in binding insulin-like peptide 3.
Scott DJ; Wilkinson TN; Zhang S; Ferraro T; Wade JD; Tregear GW; Bathgate RA
Mol Endocrinol; 2007 Jul; 21(7):1699-712. PubMed ID: 17473281
[TBL] [Abstract][Full Text] [Related]
13. Splice variants of the relaxin and INSL3 receptors reveal unanticipated molecular complexity.
Muda M; He C; Martini PG; Ferraro T; Layfield S; Taylor D; Chevrier C; Schweickhardt R; Kelton C; Ryan PL; Bathgate RA
Mol Hum Reprod; 2005 Aug; 11(8):591-600. PubMed ID: 16051677
[TBL] [Abstract][Full Text] [Related]
14. The mode of interaction of the relaxin-like factor (RLF) with the leucine-rich repeat G protein-activated receptor 8.
Büllesbach EE; Schwabe C
J Biol Chem; 2006 Sep; 281(36):26136-43. PubMed ID: 16844694
[TBL] [Abstract][Full Text] [Related]
15. GREAT/LGR8 is the only receptor for insulin-like 3 peptide.
Bogatcheva NV; Truong A; Feng S; Engel W; Adham IM; Agoulnik AI
Mol Endocrinol; 2003 Dec; 17(12):2639-46. PubMed ID: 12933905
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the rat INSL3 receptor.
Scott DJ; Fu P; Shen PJ; Gundlach A; Layfield S; Riesewijk A; Tomiyama H; Hutson JM; Tregear GW; Bathgate RA
Ann N Y Acad Sci; 2005 May; 1041():13-6. PubMed ID: 15956681
[TBL] [Abstract][Full Text] [Related]
17. Studies on soluble ectodomain proteins of relaxin (LGR7) and insulin 3 (LGR8) receptors.
Yan Y; Cai J; Fu P; Layfield S; Ferraro T; Kumagai J; Sudo S; Tang JG; Giannakis E; Tregear GW; Wade JD; Bathgate RA
Ann N Y Acad Sci; 2005 May; 1041():35-9. PubMed ID: 15956685
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of the mouse and rat relaxin receptors as the novel orthologues of human leucine-rich repeat-containing G-protein-coupled receptor 7.
Scott DJ; Layfield S; Riesewijk A; Morita H; Tregear GW; Bathgate RA
Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):828-32. PubMed ID: 15566402
[TBL] [Abstract][Full Text] [Related]
19. Synthetic human insulin 4 does not activate the G-protein-coupled receptors LGR7 or LGR8.
Lin F; Otvos L; Kumagai J; Tregear GW; Bathgate RA; Wade JD
J Pept Sci; 2004 May; 10(5):257-64. PubMed ID: 15160837
[TBL] [Abstract][Full Text] [Related]
20. H3 relaxin is a specific ligand for LGR7 and activates the receptor by interacting with both the ectodomain and the exoloop 2.
Sudo S; Kumagai J; Nishi S; Layfield S; Ferraro T; Bathgate RA; Hsueh AJ
J Biol Chem; 2003 Mar; 278(10):7855-62. PubMed ID: 12506116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
